BAY-293, an inhibitor of SOS1/Ras, was found to depress proliferation and colony formation in chronic myeloid leukemia cells with resistance and BCR-ABL independence. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.